<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05075655</url>
  </required_header>
  <id_info>
    <org_study_id>20-028</org_study_id>
    <nct_id>NCT05075655</nct_id>
  </id_info>
  <brief_title>Endobronchial Diagnosis of Lymphoma</brief_title>
  <acronym>EnDol</acronym>
  <official_title>Diagnosis of Lymphoma Using Endobronchial Ultrasound Guided Miniforceps Biopsy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study aimed to assess the diagnostic performance of ultrasound-guided&#xD;
      endobronchial intra-nodal miniforceps biopsy (EBUS-MFB) in the diagnosis of &quot;de novo&quot;&#xD;
      mediastinal lymphoma.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Every patients will be sampled using both EBUS-MFB and the standard of care EBUS-TBNA&#xD;
      (transbronchial needle aspiration).&#xD;
&#xD;
      It is a monocentric investigation. Pathologist will not know the way of sampling while&#xD;
      analysing the samples&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 20, 2021</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">April 20, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>pathologist do not know the technique of sampling used when analysing slides.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>positivity of the procedure in Diagnosis and Subtyping of lymphoma</measure>
    <time_frame>up to 3 years</time_frame>
    <description>a sample wil be considered positive if it allows the clinical management of the patient, without additional sampling required.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>every adverse effect related to the procedure</measure>
    <time_frame>up to 3 years</time_frame>
    <description>infectious process related to the procedure, hemoptysis over 50cc, worsening of respiratory status requiring hospitalization</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">33</enrollment>
  <condition>Lymphoma</condition>
  <arm_group>
    <arm_group_label>EBUS-MFB and EBUS-TBNA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patient will have both TBNA and MFB in the same operating time</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endobronchial ultrasound guided miniforceps biopsy and transbronchial needle aspiration</intervention_name>
    <description>Mediastinal node is sampled using three path of classic ultrasound guided transbronchial needle aspiration (EBUS-TBNA).&#xD;
A reduce size forceps is then inserted inside the mediastinal node via the duc EBUS-TBNA made and biopsies (EBUS-MFB) are made using real time ultrasound guidance.</description>
    <arm_group_label>EBUS-MFB and EBUS-TBNA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pathological mediastinal nodes within reach of EBUS sampling on CT-scan.&#xD;
&#xD;
          -  Lymphoma suspicion by a senior clinical hematologist&#xD;
&#xD;
          -  Affiliated to the french public health care insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Peripherical pathological lymph nodes reachable without general anesthesia&#xD;
&#xD;
          -  Antithrombotic medication that cannot be stopped le time of the procedure.&#xD;
&#xD;
          -  Unstable respiratory status&#xD;
&#xD;
          -  History of lymphoma&#xD;
&#xD;
          -  Latex or xylocaine allergia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Romain M Magnier, MD</last_name>
    <phone>0291069029</phone>
    <phone_ext>+33</phone_ext>
    <email>magnier-r@chu-caen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre M Cuchet, MD</last_name>
    <phone>0231063029</phone>
    <phone_ext>+33</phone_ext>
    <email>cuchet-p@chu-caen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CaenUH</name>
      <address>
        <city>Caen</city>
        <state>Normandy</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dutheil M Jean-Jacques</last_name>
      <phone>0231065351</phone>
      <phone_ext>+33</phone_ext>
      <email>dutheil-jj@chu-caen.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>September 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 13, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ebus</keyword>
  <keyword>endobronchial ultrasound-guided</keyword>
  <keyword>EBUS-MFB</keyword>
  <keyword>intra-nodal miniforceps biopsy</keyword>
  <keyword>EBUS-transbronchial forceps biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

